Semaglutide (Wegovy, Ozempic) is a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Zepbound, Mounjaro) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
E.LevineA
Taking a lot of lycopene can turn the skin orange, but can also cause gastrointestinal issues and slow blood clotting
The simpler phenolic compounds include monophenols with a single benzene ring, such as 3-ethylphenol and 3,4-dimethylphenol, commonly found in fruits and seeds
While Semaglutide was originally developed for type 2 diabetes, its FDA-approved specifically for weight loss in non-diabetic patients
As appetite control and metabolic health become mainstream concerns, companies must act decisively to reformulate offerings, validate health claims, and align with evolving dietary behaviours focusing on nutrition-first approach to tackle these shifts